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Malignant melanoma (MM) represents one of the
most aggressive neoplasms and its frequency is
increasing rapidly. Increased melanoma risk among
relatives of MM patients and familial aggregations of
this malignancy point at genetic predisposition as an
important factor of MM pathogenesis. The genetic
basis of MM is complex and appears to involve multi-
ple genes. CDKN2A is regarded as the major MM sus-
ceptibility gene. In the Polish population common
CDKN2A variant (A148T) increases significantly mela-
noma risk regardless of the cancer family history.
Mutations of other high risk genes, ARF and CDK4
are extremely rare. The higher rates of CDKN2A/p16
mutations can be detected only in rare cases charac-
terized by:
1) occurrence of three or more primary melanomas,
2) patients with three or more melanomas in aggre-
gate among first or second degree relatives,
3) families with the presence of three or more cases of
melanoma and/or pancreatic cancer on the same side of
the family.
It is thus necessary to perform association studies
focused on identifying genetic markers that could be
used in identifying patients with a high risk of MM. List
of other genes that carry mutations, which are believed
to be associated with moderate MM risk include XPD,
MC1R, BRCA2. Newest genome-wide association study
identified three loci associated with melanoma risk:
16q24, 11q14-q21, 9p21.
The management with individuals being at increased
MM risk involves clinical screening according to care-
fully planned surveillance schedule and early treatment
of MM tumour. The appropriate management may
reduce morbidity and mortality. Genetic testing and
clinical evaluation should be performed, and family
history should be obtained in all patients affected with
MM, also in those with apparently sporadic tumours.
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